The PTEN-AKT-mTOR/RICTOR Pathway in Nasal Natural Killer Cell Lymphoma Is Activated by miR-494-3p via PTEN But Inhibited by miR-142-3p via RICTOR.

@article{Chen2015ThePP,
  title={The PTEN-AKT-mTOR/RICTOR Pathway in Nasal Natural Killer Cell Lymphoma Is Activated by miR-494-3p via PTEN But Inhibited by miR-142-3p via RICTOR.},
  author={Hao-Hui Chen and Wei-ting Huang and Li-Wei Yang and Chung-Wu Lin},
  journal={The American journal of pathology},
  year={2015},
  volume={185 5},
  pages={
          1487-99
        }
}
Nasal natural killer (NK) cell lymphoma (NNL) is an Epstein-Barr virus-associated lymphoma of cytotoxic NK cell origin. The Epstein-Barr virus-encoded miR-BART20-5p inhibits T-bet (TBX21), the master transcription factor of cytotoxic NK cells. To further explore the roles of miRNAs in NNLs, we measured the miRNA expression profiles of 36 NNLs. miR-21, miR-142-3p, miR-126, miR-451, and miR-494-3p were the top five miRNAs with the highest expression levels. By using pathway analysis, we… CONTINUE READING
1
Twitter Mention

Citations

Publications citing this paper.
SHOWING 1-10 OF 16 CITATIONS

Non-coding RNAs in Natural Killer/T-Cell Lymphoma

  • Front. Oncol.
  • 2019
VIEW 5 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

Host MicroRNA hsa-miR-494-3p Promotes EV71 Replication by Directly Targeting PTEN

  • Front. Cell. Infect. Microbiol.
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

MicroRNA-142-3p Induces Atherosclerosis-Associated Endothelial Cell Apoptosis by Directly Targeting Rictor.

  • Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
  • 2018

References

Publications referenced by this paper.
SHOWING 1-10 OF 55 REFERENCES

Akt enhances Mdm2-mediated ubiquitination and degradation of p53.

  • The Journal of biological chemistry
  • 2002
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network.

  • Trends in biochemical sciences
  • 2002
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Status of PI3K/Akt/mTOR pathway inhibitors in lymphoma.

  • Clinical lymphoma, myeloma & leukemia
  • 2014
VIEW 1 EXCERPT

MicroRNA-142-3p inhibits cell proliferation in human acute lymphoblastic leukemia by targeting the MLL-AF4 oncogene

Liping Dou, Jingxin Li, +6 authors Li Yu
  • Molecular Biology Reports
  • 2013
VIEW 1 EXCERPT